Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

I take credit/blame for the PolyMedix discussion. For me it is actually one of the better features of Cellceutix. Obviously that company failed, but their pipeline of drugs (which is only a third of Cellceutix's current trial drugs) was valued by professional analysts at $227 million. Even if one were to believe the ridiculous notion that the drugs Menon developed don't work, you still have to account for the fact that the Brilacidin research was done by a totally different company. Polymedix problems were from bad timing (no love for antibiotics), bad trial results on a drug they chose to lead with, and a management that proved ineffective at raising capital at a critical juncture.

So ya, I give the management at Cellceutix very good marks so far!